Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Carlos Kamiya-Matsouka"'
Autor:
John de Groot, Martina Ott, Jun Wei, Cynthia Kassab, Dexing Fang, Hinda Najem, Barbara O'Brien, Shiao-Pei Weathers, Carlos Kamiya Matsouka, Nazanin K Majd, Rebecca A Harrison, Gregory N Fuller, Jason T Huse, James P Long, Raymond Sawaya, Ganesh Rao, Tobey J MacDonald, Waldemar Priebe, Michael DeCuypere, Amy B Heimberger
Publikováno v:
CNS Oncology, Vol 11, Iss 02 (2022)
Aim: To ascertain the maximum tolerated dose (MTD)/maximum feasible dose (MFD) of WP1066 and p-STAT3 target engagement within recurrent glioblastoma (GBM) patients. Patients & methods: In a first-in-human open-label, single-center, single-arm 3 + 3 d
Externí odkaz:
https://doaj.org/article/f172809d74d443f2aaf6cc04d8836b6d
Autor:
Jacob Mandel, Padmanee Sharma, Ganesh Rao, Shouhao Zhou, Jorge Blando, Be Lian Pei, Jimin Wu, Kathy Hunter, Monica Loghin, Shalini S. Yadav, Gregory N. Fuller, Sujit S. Prabhu, Ying Yuan, Frederick F. Lang, Rivka R. Colen, Raymond Sawaya, W. K. Alfred Yung, Carlos Kamiya Matsouka, Jeffrey S. Weinberg, Jason T. Huse, Amy B. Heimberger, James P. Allison, Kristin Alfaro-Munoz, Sherise D. Ferguson, John de Groot, Ian E. McCutcheon, Barbara O’Brien, Luis M Vence, Marta Penas-Prado, Shiao Pei Weathers
Publikováno v:
Neuro Oncol
Background We sought to ascertain the immune effector function of pembrolizumab within the glioblastoma (GBM) microenvironment during the therapeutic window. Methods In an open-label, single-center, single-arm phase II “window-of-opportunity” tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::607f0e315165e0e23a7ca76519f6e103
https://doi.org/10.1093/neuonc/noz185
https://doi.org/10.1093/neuonc/noz185
Autor:
Shiao-Pei Weathers, Marta Penas-Prado, Shalini S. Yadav, Barbara O’Brien, Sherise Desiree Ferguson, W. K. Alfred Yung, Jorge Blando, Monica Loghin, Rivka R. Colen, Jacob Mandel, John de Groot, Gregory N. Fuller, Jason T. Huse, Kathy Hunter, Ying Yuan, Amy B. Heimberger, Jeffrey S. Weinberg, James P. Allison, Carlos Kamiya Matsouka, Sujit S. Prabhu, Padmanee Sharma, Shouhao Zhou, Ganesh Rao, Kristin D. Alfaro-Munoz, Frederick F. Lang, Luis Vence, Ian E. McCutcheon, Raymond Sawaya
Publikováno v:
SSRN Electronic Journal.
Background: We sought to ascertain the immune effector function of pembrolizumab within the glioblastoma (GBM) microenvironment during the therapeutic window. Methods: In an open-label, single-center, single-arm phase 2 "window-of-opportunity" trial,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6bdc9ac1de5d9729941f79eb1e3a1f75
https://doi.org/10.2139/ssrn.3264987
https://doi.org/10.2139/ssrn.3264987
Autor:
Naval Daver, Chelsea C. Pinnix, Linda Chi, Karen Woodman, Carlos Kamiya-Matsouka, David Cachia
Publikováno v:
Neuro-Oncology. 16:v46-v46
Intrathecal (IT) chemotherapy in combination with systemic chemotherapy is an effective treatment modality used in the prophylaxis and treatment of CNS disease in hematological malignancies. IT agents commonly used in various chemotherapeutic regimen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::453c42ca9a00375ab496b88d5c049f2b
https://doi.org/10.1093/neuonc/nou243.2
https://doi.org/10.1093/neuonc/nou243.2